Skip to content

Long Term Function Outcomes and Pain in Implant-based Post-mastectomy Breast Reconstruction

The Impact of Operative Approach on Long Term Function Outcomes and Pain in Implant-based Post-mastectomy Breast Reconstruction

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04477538
Enrollment
240
Registered
2020-07-20
Start date
2020-07-07
Completion date
2021-11-08
Last updated
2024-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-mastectomy Breast Reconstruction

Brief summary

The objective of this proposal is to broadly assess patient physical functioning following breast reconstruction.

Interventions

OTHERPost-mastectomy breast reconstruction physical well-being survey

-The survey will ascertain: function status (BREAST Q - Physical Well Being Module and PROMIS upper extremity function), former interaction with physical or occupational therapy, amount of narcotics taken weekly due to chest/neck/breast pain, amount of Tylenol or similar anti-inflammatories taken weekly due to chest/neck/breast pain, and amount of muscle relaxants taken weekly due to chest/neck/breast pain.

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female * At least 18 years of age * Had a mastectomy for breast cancer or cancer prevention any time between 01/01/2010 and 06/30/2021. * Has undergone breast reconstruction surgery with plastic surgery faculty at the Washington University School of Medicine Division of Plastic and Reconstructive Surgery. * Able to understand and willing to sign an IRB-approved written informed consent document.

Exclusion criteria

-Known distant metastatic disease

Design outcomes

Primary

MeasureTime frameDescription
Compare the physical well-being Q-score derived from the BREAST-Q between the two groupsCompletion of study (estimated to be 30 months)The physical well-being module is one of the domains of the BREAST-Q that can be administered in isolation. Patients answer specific questions with answers that range from 1-4 to 1-5. Upon completion of this component of the survey, a physical well-being-specific numerical score is generated. This is then converted, based on previously published Rasch-modeling to generate a Q-score whose values range from 0-100. This same approach is used for all other domains of the BREAST-Q. Pre- versus postoperative Q-scores for physical well-being can be directly compared to study the impact of surgery on physical well-being. Similarly, the physical-well-being domain can be readministered to provide a longitudinal assessment of physical function over time.

Secondary

MeasureTime frameDescription
Satisfaction with outcomeCompletion of study (estimated to be 30 months)-The satisfaction with outcome module is one of the domains of the BREAST-Q. Patients answer specific questions with answers that range from 1-3. Upon completion of this component of the survey, a specific numerical score is generated. This is then converted, based on previously published Rasch-modeling to generate a Q-score whose values range from 0-100.
Upper extremity function as measured by PROMIS Upper Extremity Short Form 7aCompletion of study (estimated to be 30 months)-Questions regarding upper extremity function as reported by patient. Answers range from 5=without any difficulty to 1=unable to do. The total score ranges from 5-35.
Satisfaction with breastsCompletion of study (estimated to be 30 months)-The satisfaction with breast module is one of the domains of the BREAST-Q. Patients answer specific questions with answers that range from 1-4. Upon completion of this component of the survey, a specific numerical score is generated. This is then converted, based on previously published Rasch-modeling to generate a Q-score whose values range from 0-100.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026